Neuren Pharmaceuticals | NEU - Gross Profit On Sales



Neuren Pharmaceuticals reported 322K in Gross Profit on Sales for its fiscal semester ending in June of 2024.


Gross Profit On Sales Change Date
Alaunos Therapeutics -1127000 1.11M Sep/2024
Avita Medical AUD 16.13M 3.05M Dec/2024
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Dianthus Therapeutics 193K 970K Jun/2025
Genetic Signatures AUD 4.75M 190K Dec/2024
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
Medical Developments International AUD 14.72M 1.36M Dec/2024
Organon & Co USD 874M 33M Jun/2025
Paradigm Biopharmaceuticals AUD 414.94K 4.82M Dec/2024
PYC Therapeutics AUD 6.58M 2.13M Jun/2024
Starpharma Holdings AUD 2.08M 3.82M Dec/2024
Tectonic Therapeutic 0 0 Mar/2025
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024
Viatris USD 1.33B 98.1M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025